BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 12699957)

  • 1. Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease.
    Biezeveld MH; Kuipers IM; Geissler J; Lam J; Ottenkamp JJ; Hack CE; Kuijpers TW
    Lancet; 2003 Apr; 361(9365):1268-70. PubMed ID: 12699957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ambiguous role of mannose-binding lectin (MBL) in human immunity.
    Kalia N; Singh J; Kaur M
    Open Med (Wars); 2021; 16(1):299-310. PubMed ID: 33681468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the Lectin Complement Pathway Link Kawasaki Disease and SARS-CoV-2?
    Polycarpou A; Grigoriadou S; Klavinskis L; Sacks S
    Front Immunol; 2020; 11():604512. PubMed ID: 33584675
    [No Abstract]   [Full Text] [Related]  

  • 4. Kawasaki disease: pathophysiology and insights from mouse models.
    Noval Rivas M; Arditi M
    Nat Rev Rheumatol; 2020 Jul; 16(7):391-405. PubMed ID: 32457494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Permeability and IgA Provoke Immune Vasculitis Linked to Cardiovascular Inflammation.
    Noval Rivas M; Wakita D; Franklin MK; Carvalho TT; Abolhesn A; Gomez AC; Fishbein MC; Chen S; Lehman TJ; Sato K; Shibuya A; Fasano A; Kiyono H; Abe M; Tatsumoto N; Yamashita M; Crother TR; Shimada K; Arditi M
    Immunity; 2019 Sep; 51(3):508-521.e6. PubMed ID: 31471109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mannose-binding lectin (MBL) codon 54 (rs1800450) polymorphism predisposes towards medium vessel vasculitis in patients with systemic lupus erythematosus.
    Negi VS; Devaraju P; Misra DP; Jain VK; Usdadiya JB; Antony PT; Gulati R
    Clin Rheumatol; 2017 Apr; 36(4):837-843. PubMed ID: 28097447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannose-Binding Lectin Levels and Carotid Intima-Media Thickness in Type 2 Diabetic Patients.
    Káplár M; Sweni S; Kulcsár J; Cogoi B; Esze R; Somodi S; Papp M; Oláh L; Magyar MT; Szabó K; Czuriga-Kovács KR; Hársfalvi J; Paragh G
    J Diabetes Res; 2016; 2016():8132925. PubMed ID: 26640806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma MASP-1 concentration and its relationship to recovery from coronary artery lesion in children with Kawasaki disease.
    Song RX; Zou QM; Li XH; Xu NP; Zhang T; Fu J; Cui XD
    Pediatr Res; 2016 Feb; 79(2):301-7. PubMed ID: 26536449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular health late after Kawasaki disease: implications for accelerated atherosclerosis.
    Cheung YF
    Korean J Pediatr; 2014 Nov; 57(11):472-8. PubMed ID: 25550701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannan-binding lectin in cardiovascular disease.
    Pągowska-Klimek I; Cedzyński M
    Biomed Res Int; 2014; 2014():616817. PubMed ID: 24877121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between serum mannose-binding lectin levels and acute ischemic stroke risk.
    Wang ZY; Sun ZR; Zhang LM
    Neurochem Res; 2014 Feb; 39(2):248-53. PubMed ID: 24309995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma clusterin concentrations may predict resistance to intravenous immunoglobulin in patients with Kawasaki disease.
    Ou-Yang MC; Kuo HC; Lin IC; Sheen JM; Huang FC; Chen CC; Huang YH; Lin YJ; Yu HR
    ScientificWorldJournal; 2013; 2013():382523. PubMed ID: 23956692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of infection in Kawasaki syndrome.
    Principi N; Rigante D; Esposito S
    J Infect; 2013 Jul; 67(1):1-10. PubMed ID: 23603251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the pathogenesis of Kawasaki disease by network and pathway analysis.
    Lv YW; Wang J; Sun L; Zhang JM; Cao L; Ding YY; Chen Y; Dou JJ; Huang J; Tang YF; Wu WT; Cui WR; Lv HT
    Comput Math Methods Med; 2013; 2013():989307. PubMed ID: 23533546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between CLEC5A gene single-nucleotide polymorphisms and Kawasaki disease in Taiwanese children.
    Yang YL; Chang WP; Hsu YW; Chen WC; Yu HR; Liang CD; Tsai YT; Huang YH; Yang KD; Kuo HC; Chang WC
    J Biomed Biotechnol; 2012; 2012():398628. PubMed ID: 22536019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta receptor II polymorphisms are associated with Kawasaki disease.
    Choi YM; Shim KS; Yoon KL; Han MY; Cha SH; Kim SK; Jung JH
    Korean J Pediatr; 2012 Jan; 55(1):18-23. PubMed ID: 22359526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights of an old defense system: structure, function, and clinical relevance of the complement system.
    Ehrnthaller C; Ignatius A; Gebhard F; Huber-Lang M
    Mol Med; 2011; 17(3-4):317-29. PubMed ID: 21046060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease.
    Yu HR; Kuo HC; Huang EY; Liang CD; Hwang KP; Lin IC; Sheen JM; Wang TJ; Wang CL; Yang KD
    Pediatr Cardiol; 2010 Nov; 31(8):1151-6. PubMed ID: 20711835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kawasaki disease: novel insights into etiology and genetic susceptibility.
    Rowley AH
    Annu Rev Med; 2011; 62():69-77. PubMed ID: 20690826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant form of human wild type mannan-binding lectin (MBL/A) but not its structural variant (MBL/C) promotes phagocytosis of zymosan by activating complement.
    Rajagopalan R; Nyaundi T; Salvi VP; Rawal N
    Mol Immunol; 2010 Sep; 47(15):2505-14. PubMed ID: 20579738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.